These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7875689)

  • 1. The development of anti-hepatitis C virus agents.
    Shimotohno K
    Hepatology; 1995 Mar; 21(3):887-8. PubMed ID: 7875689
    [No Abstract]   [Full Text] [Related]  

  • 2. Unique composite active site of the hepatitis C virus NS2-3 protease: a new opportunity for antiviral drug design.
    Suo Z; Abdullah MA
    ChemMedChem; 2007 Mar; 2(3):283-4. PubMed ID: 17266160
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and evaluation of 5'-modified 2'-deoxyadenosine analogues as anti-hepatitis C virus agents.
    Ikejiri M; Ohshima T; Fukushima A; Shimotohno K; Maruyama T
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4638-41. PubMed ID: 18644724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents.
    Yoo BN; Kim HO; Moon HR; Seol SK; Jang SK; Lee KM; Jeong LS
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4190-4. PubMed ID: 16781148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.
    Tsantrizos YS; Bolger G; Bonneau P; Cameron DR; Goudreau N; Kukolj G; LaPlante SR; Llinàs-Brunet M; Nar H; Lamarre D
    Angew Chem Int Ed Engl; 2003 Mar; 42(12):1356-60. PubMed ID: 12671967
    [No Abstract]   [Full Text] [Related]  

  • 6. 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph.
    Meanwell NA
    J Med Chem; 2016 Aug; 59(16):7311-51. PubMed ID: 27501244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis C virus internal ribosome-entry site: a new target for antiviral research.
    Gallego J; Varani G
    Biochem Soc Trans; 2002 Apr; 30(2):140-5. PubMed ID: 12023841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).
    McGuigan C; Kelleher MR; Perrone P; Mulready S; Luoni G; Daverio F; Rajyaguru S; Le Pogam S; Najera I; Martin JA; Klumpp K; Smith DB
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4250-4. PubMed ID: 19505826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel, potent phenethylamide inhibitors of the hepatitis C virus (HCV) NS3 protease: probing the role of P2 aryloxyprolines with hybrid structures.
    Orvieto F; Koch U; Matassa VG; Muraglia E
    Bioorg Med Chem Lett; 2003 Aug; 13(16):2745-8. PubMed ID: 12873506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Achilles' heel of hepatitis C virus.
    Lemon SM
    Hepatology; 1997 Apr; 25(4):1035-7. PubMed ID: 9096617
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.
    Hahm B; Back SH; Lee TG; Wimmer E; Jang SK
    Virology; 1996 Dec; 226(2):318-26. PubMed ID: 8955051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral Research--16th International Congress: HBV and HCV. 27 April-1 May 2003, Savannah, GA, USA.
    Smee D
    IDrugs; 2003 Jun; 6(6):518-21. PubMed ID: 12861975
    [No Abstract]   [Full Text] [Related]  

  • 14. [The recent progress on experimental models and molecular virology of hepatitis C virus].
    Zhong J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):494-6. PubMed ID: 19912681
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genomic changes in the E2/NS1 region of HCV before and after IFN therapy].
    Higashi Y; Kakumu S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):923-9. PubMed ID: 7563902
    [No Abstract]   [Full Text] [Related]  

  • 16. [Different effect of interferon on hepatitis C virus genomes using CAT expression system].
    Yanagi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):936-43. PubMed ID: 7563905
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
    Sakuma I; Enomoto N; Asahina Y; Kurosaki M; Sato C
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):930-5. PubMed ID: 7563904
    [No Abstract]   [Full Text] [Related]  

  • 18. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
    McGuigan C; Perrone P; Madela K; Neyts J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B.
    Zhang N; Turpoff A; Zhang X; Huang S; Liu Y; Almstead N; Njoroge FG; Gu Z; Graci J; Jung SP; Pichardo J; Colacino J; Lahser F; Ingravallo P; Weetall M; Nomeir A; Karp GM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):594-601. PubMed ID: 26652483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 3'-C-hydroxymethyl-substituted pyrimidine and purine nucleosides as potential anti-hepatitis C virus (HCV) agents.
    Pei X; Choi WJ; Kim YM; Zhao LX; Jeong LS
    Arch Pharm Res; 2008 Jul; 31(7):843-9. PubMed ID: 18704325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.